» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 124 | NO. 121 | Tuesday, June 23, 2009

FTC Requests More Info from Merck, Schering-Plough

AP

Print | Front Page | Email this story | Comments ()

NEW YORK (AP) - Drugmakers Merck and Co. and Schering-Plough Corp., which are in the process of a $41.1 billion tie-up, said Monday the Federal Trade Commission has asked for more information about the deal.

Merck, of Whitehouse Station, N.J., and Schering-Plough, Kenilworth, N.J., said they expected the request, which was made under federal antitrust law. The companies intend to cooperate with the request.

Merck agreed to buy Schering-Plough in March, and the companies still expect the deal to close in the fourth quarter. The transaction also requires approval by Merck and Schering-Plough shareholders.

The combined company would be the world's second-largest drugmaker by revenue, with products including the asthma drug Singulair, Nasonex for allergies, and the cholesterol drugs Zetia and Vytorin.

Merck also said Monday it plans to issue about $3.5 billion in debt to fund the Schering-Plough acquisition. Some of the proceeds may also be used for Vioxx lawsuit settlement funds.

In Monday morning trading, Merck shares lost 52 cents, or 2 percent, to $25.39, and Schering-Plough slid 25 cents to $23.55.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog Get more from The Daily News
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 72 368 16,413
MORTGAGES 66 422 21,432
FORECLOSURE NOTICES 15 76 4,266
BUILDING PERMITS 176 877 39,378
BANKRUPTCIES 60 294 15,542
BUSINESS LICENSES 20 98 5,491
UTILITY CONNECTIONS 69 423 23,573
MARRIAGE LICENSES 17 95 5,035

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.